NCT06904196 2025-04-29
Lenvatinib Plus SIRT vs Lenvatinib in TACE-Refractory HCC
Second Affiliated Hospital of Guangzhou Medical University
Phase 2 Recruiting
Clinical Trials
5 trialsNCT02936388 2025-01-24
SirTac
Charite University, Berlin, Germany
Phase 2 Completed
NCT05992584 2023-09-14
Lenvatinib, Sintilimab Plus SIRT for Unresectable HCC
Second Affiliated Hospital of Guangzhou Medical University
Phase 2 Recruiting
NCT01126645 2019-05-31
SORAMIC
University of Magdeburg
Phase 2 Completed
NCT01798147 2017-05-23
Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Cholangiocellular Carcinoma (CCC).
Johannes Gutenberg University Mainz
Phase 2 Unknown